The A2Z Market Research report on “Global Gene Therapy for Neurodegenerative Diseases Market Report 2024 – Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030” offers strategic visions into the global Gene Therapy for Neurodegenerative Diseases market along with the market size (Volume – Million Units and Revenue – US$ Billion) and estimates for the duration 2024 to 2030. The said research study covers in-depth analysis of multiple market segments based on type, application, and studies different topographies. The report is also inclusive of competitive profiling of the leading Gene Therapy for Neurodegenerative Diseases product vendors, and their latest developments.
This report has been segmented by type, by application and by geography and also includes the market size and forecast for all these segments. Compounded annual growth rates for all segments have also been provided for 2024 to 2030. The study highlights current market trends for Gene Therapy for Neurodegenerative Diseases and also provides the future trends that will impact the demand. Year-on-year growth rates are also provided for each segment covered in the global Gene Therapy for Neurodegenerative Diseases market report. The report also analyzes the market from production perspective and includes raw material cost analysis, technology cost analysis, labor cost analysis, and cost overview for the Gene Therapy for Neurodegenerative Diseases market.
By geography, the market has been segmented into North America, South America, Asia, Europe, Africa and Others. Under North America, the report covers the United States, and Canada; whereas Asia includes China, Japan, India, Korea, and Southeast Asia. The key countries covered under Europe include Germany, United Kingdom, France, and Russia whereas ‘Others’ is comprised of Middle East and GCC countries. The present market size and forecast till 2030 for all the regions and sub-regions have also been provided in the report.
This report covers the Major Players’ data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. It also includes competitive scenario in the market and offers insights into the manufacturer share from 2015 to 2018 both in terms of shipment and revenue for all major players identified in the global Gene Therapy for Neurodegenerative Diseases market. Other key parameters include plant location, technology source, downstream industry, and contact information among others.
Some of the important players in Gene Therapy for Neurodegenerative Diseases market are:
Voyager Therapeutics
Uniqure
Axovant Gene Therapies
Novartis Ag
Amicus Therapeutics
Regenxbio Inc.
Sarepta Therapeutics
Gensight Biologics
Krystal Biotech
Avexis
Market segmentation by Type:
Gene Replacement Therapy
Gene Silencing Therapy
Gene Editing Therapy
Enzyme Replacement Therapy
Market segmentation by Application:
Hospitals and Clinics
Research Institutions
Biotechnology Companies
Others
Table of Content
Global Gene Therapy for Neurodegenerative Diseases Market Research Report 2024 - Future Opportunities, Latest Trends, In-depth Analysis, and Forecast To 2030
Chapter 1 Gene Therapy for Neurodegenerative Diseases Market Overview
1.1 Product Overview and Scope of Gene Therapy for Neurodegenerative Diseases
1.2 Gene Therapy for Neurodegenerative Diseases Market Segmentation by Type
1.2.1 Global Production Market Share of Gene Therapy for Neurodegenerative Diseases by Type in 2024
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Gene Therapy for Neurodegenerative Diseases Market Segmentation by Application
1.3.1 Gene Therapy for Neurodegenerative Diseases Consumption Market Share by Application in 2024
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Gene Therapy for Neurodegenerative Diseases Market Segmentation by Regions
1.4.1 North America
1.4.2 China
1.4.3 Europe
1.4.4 Southeast Asia
1.4.5 Japan
1.4.6 India
1.5 Global Market Size (Value) of Gene Therapy for Neurodegenerative Diseases (2018-2030)
Chapter 2 Global Economic Impact on Gene Therapy for Neurodegenerative Diseases Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions
Chapter 3 Global Gene Therapy for Neurodegenerative Diseases Market Competition by Manufacturers
3.1 Global Gene Therapy for Neurodegenerative Diseases Production and Share by Manufacturers (2024 and 2024)
3.2 Global Gene Therapy for Neurodegenerative Diseases Revenue and Share by Manufacturers (2024 and 2024)
3.3 Global Gene Therapy for Neurodegenerative Diseases Average Price by Manufacturers (2024 and 2024)
3.4 Manufacturers Gene Therapy for Neurodegenerative Diseases Manufacturing Base Distribution, Production Area and Product Type
3.5 Gene Therapy for Neurodegenerative Diseases Market Competitive Situation and Trends
3.5.1 Gene Therapy for Neurodegenerative Diseases Market Concentration Rate
3.5.2 Gene Therapy for Neurodegenerative Diseases Market Share of Top 3 and Top 5 Manufacturers
3.5.3 Mergers & Acquisitions, Expansion
Chapter 4 Global Gene Therapy for Neurodegenerative Diseases Production, Revenue (Value) by Region (2018-2024)
4.1 Global Gene Therapy for Neurodegenerative Diseases Production by Region (2018-2024)
4.2 Global Gene Therapy for Neurodegenerative Diseases Production Market Share by Region (2018-2024)
4.3 Global Gene Therapy for Neurodegenerative Diseases Revenue (Value) and Market Share by Region (2018-2024)
4.4 Global Gene Therapy for Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2018-2024)
4.5 North America Gene Therapy for Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2018-2024)
4.6 Europe Gene Therapy for Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2018-2024)
4.7 China Gene Therapy for Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2018-2024)
4.8 Japan Gene Therapy for Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2018-2024)
4.9 Southeast Asia Gene Therapy for Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2018-2024)
4.10 India Gene Therapy for Neurodegenerative Diseases Production, Revenue, Price and Gross Margin (2018-2024)
Chapter 5 Global Gene Therapy for Neurodegenerative Diseases Supply (Production), Consumption, Export, Import by Regions (2018-2024)
5.1 Global Gene Therapy for Neurodegenerative Diseases Consumption by Regions (2018-2024)
5.2 North America Gene Therapy for Neurodegenerative Diseases Production, Consumption, Export, Import by Regions (2018-2024)
5.3 Europe Gene Therapy for Neurodegenerative Diseases Production, Consumption, Export, Import by Regions (2018-2024)
5.4 China Gene Therapy for Neurodegenerative Diseases Production, Consumption, Export, Import by Regions (2018-2024)
5.5 Japan Gene Therapy for Neurodegenerative Diseases Production, Consumption, Export, Import by Regions (2018-2024)
5.6 Southeast Asia Gene Therapy for Neurodegenerative Diseases Production, Consumption, Export, Import by Regions (2018-2024)
5.7 India Gene Therapy for Neurodegenerative Diseases Production, Consumption, Export, Import by Regions (2018-2024)
Chapter 6 Global Gene Therapy for Neurodegenerative Diseases Production, Revenue (Value), Price Trend by Type
6.1 Global Gene Therapy for Neurodegenerative Diseases Production and Market Share by Type (2018-2024)
6.2 Global Gene Therapy for Neurodegenerative Diseases Revenue and Market Share by Type (2018-2024)
6.3 Global Gene Therapy for Neurodegenerative Diseases Price by Type (2018-2024)
6.4 Global Gene Therapy for Neurodegenerative Diseases Production Growth by Type (2018-2024)
Chapter 7 Global Gene Therapy for Neurodegenerative Diseases Market Analysis by Application
7.1 Global Gene Therapy for Neurodegenerative Diseases Consumption and Market Share by Application (2018-2024)
7.2 Global Gene Therapy for Neurodegenerative Diseases Consumption Growth Rate by Application (2018-2024)
7.3 Market Drivers and Opportunities
7.3.1 Potential Applications
7.3.2 Emerging Markets/Countries
Chapter 8 Gene Therapy for Neurodegenerative Diseases Manufacturing Cost Analysis
8.1 Gene Therapy for Neurodegenerative Diseases Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Gene Therapy for Neurodegenerative Diseases
Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Gene Therapy for Neurodegenerative Diseases Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Gene Therapy for Neurodegenerative Diseases Major Manufacturers in 2024
9.4 Downstream Buyers
Chapter 10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
Chapter 11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
Chapter 12 Global Gene Therapy for Neurodegenerative Diseases Market Forecast (2024-2030)
12.1 Global Gene Therapy for Neurodegenerative Diseases Production, Revenue Forecast (2024-2030)
12.2 Global Gene Therapy for Neurodegenerative Diseases Production, Consumption Forecast by Regions (2024-2030)
12.3 Global Gene Therapy for Neurodegenerative Diseases Production Forecast by Type (2024-2030)
12.4 Global Gene Therapy for Neurodegenerative Diseases Consumption Forecast by Application (2024-2030)
12.5 Gene Therapy for Neurodegenerative Diseases Price Forecast (2024-2030)
Chapter 13 Appendix